Celldex Therapeutics logo
Celldex Therapeutics CLDX
$ 31.48 1.35%

Annual report 2025
added 02-25-2026

report update icon

Celldex Therapeutics Operating Cycle 2011-2026 | CLDX

Annual Operating Cycle Celldex Therapeutics

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
321 86.5 78.9 40.2 77.5 69.3 - - - - - - 43.4 1.43 6.7

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
321 1.43 80.5

Quarterly Operating Cycle Celldex Therapeutics

2025-Q3 2025-Q2 2025-Q1 2024-Q4 2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
- 72.1 116 - 34.1 76.8 1.55 K - 11.1 244 78.4 - 32.1 95.2 109 - 207 30.5 242 43.4 246 697 47.1 104 170 130 134 164 307 104 56.5 49.6 43.7 44.8 109 86.9 73.3 117 96.4 49.5 86.3 40.6 131 26.4 35.4 65.8 100 72 45.5 460 10.1 1.1 1.29 2 4.01 6.38 6.56 7.95 -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
1.55 K 1.1 130

Operating Cycle of other stocks in the Biotechnology industry

Issuer Operating Cycle Price % 24h Market Cap Country
Akebia Therapeutics Akebia Therapeutics
AKBA
210 $ 1.35 -2.17 % $ 347 M usaUSA
Alnylam Pharmaceuticals Alnylam Pharmaceuticals
ALNY
102 $ 330.71 3.72 % $ 43.3 B usaUSA
Altimmune Altimmune
ALT
7.85 K $ 3.47 3.89 % $ 306 M usaUSA
Amgen Amgen
AMGN
282 $ 346.45 -0.43 % $ 186 B usaUSA
I-Mab I-Mab
IMAB
271 - - $ 866 M chinaChina
Amneal Pharmaceuticals Amneal Pharmaceuticals
AMRX
117 $ 12.37 -0.92 % $ 3.88 B usaUSA
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc.
ALXN
12.8 - - $ 40.3 B usaUSA
Anika Therapeutics Anika Therapeutics
ANIK
325 $ 15.0 1.32 % $ 220 M usaUSA
ANI Pharmaceuticals ANI Pharmaceuticals
ANIP
295 $ 76.34 2.87 % $ 1.47 B usaUSA
Aptorum Group Limited Aptorum Group Limited
APM
4.89 $ 0.92 -1.11 % $ 5.02 M chinaChina
Midatech Pharma plc Midatech Pharma plc
MTP
245 - -18.52 % $ 27.3 M britainBritain
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
32 - -1.52 % $ 24.7 M usaUSA
Aquestive Therapeutics Aquestive Therapeutics
AQST
223 $ 4.15 0.48 % $ 444 M usaUSA
Arcturus Therapeutics Holdings Arcturus Therapeutics Holdings
ARCT
21.2 $ 8.43 4.98 % $ 231 M israelIsrael
Ardelyx Ardelyx
ARDX
1.05 K $ 6.08 2.27 % $ 1.47 B usaUSA
Acorda Therapeutics Acorda Therapeutics
ACOR
394 - -24.86 % $ 820 K usaUSA
Arcutis Biotherapeutics Arcutis Biotherapeutics
ARQT
291 $ 23.93 1.27 % $ 3.04 B usaUSA
Arvinas Arvinas
ARVN
4.66 $ 11.11 2.4 % $ 788 M usaUSA
Arrowhead Pharmaceuticals Arrowhead Pharmaceuticals
ARWR
8.75 $ 61.57 0.88 % $ 8.24 B usaUSA
Advaxis Advaxis
ADXS
88.1 - -9.65 % $ 45.9 M usaUSA
Assembly Biosciences Assembly Biosciences
ASMB
25.1 $ 30.01 3.43 % $ 336 M usaUSA
Aeterna Zentaris Aeterna Zentaris
AEZS
115 - 5.93 % $ 314 M canadaCanada
AgeX Therapeutics AgeX Therapeutics
AGE
186 - -10.17 % $ 12.2 K usaUSA
AIkido Pharma AIkido Pharma
AIKI
17.9 - 1.93 % $ 17.4 M usaUSA
Институт стволовых клеток человека Институт стволовых клеток человека
ISKJ
104 - - - russiaRussia
Atossa Therapeutics Atossa Therapeutics
ATOS
249 $ 5.21 -2.89 % $ 44.9 M usaUSA
Atara Biotherapeutics Atara Biotherapeutics
ATRA
4.13 $ 5.03 0.7 % $ 63.1 M usaUSA
Aurinia Pharmaceuticals Aurinia Pharmaceuticals
AUPH
659 $ 16.04 2.75 % $ 2.16 B canadaCanada
Autolus Therapeutics plc Autolus Therapeutics plc
AUTL
129 $ 1.42 0.35 % $ 378 M britainBritain
Alpine Immune Sciences Alpine Immune Sciences
ALPN
154 - - $ 2.17 B usaUSA